Endoscopic Stapling System for Trans Oral Treatment of GERD -Three Years Follow up
Aviel Roy-Shapira*1,2, Amol Bapaye3
1Surgery A, Soroka Univesity Hospital, Beer Sheva, Israel; 2Faculty of the Health Sciences, Ben Gurion University, Beer Sheva, Israel; 3Deenanath Mangeshkar Hospital and Research Center, Pune, India
Objectives: Long Term Efficacy of an endoscopic staling system for trans oral treatment of GERDIntroduction: Between May and October 2007, an IRB approved, pilot study of a new endoscopic stapling device for the treatment of GERD was conducted on 13 subjects in Pune, India. Subjects with history of PPI use > 2y for GERD and no co-morbidity were included. The device is a modified gastroscope, which includes a surgical stapler, that fires a staggered quintuplet of standard titanium B shaped 4.8mm staples, and an ultrasonic range finder. All procedures were done under general anesthesia by a single operator. Either 2 or 3 staple quintuplets were used to staple the fundus to the esophagus,creating a 90-180 degree anterior fundoplication over the distal 2-3cm of the esophagus. This is a report of the results of a three year follow up on this group of subjectsMethods: The original Informed consent specified that the subjects may be contacted annually for 5 years following the study. Accordingly subjects were contacted for a telephone interview during the first week of October 2010. The following data were collected: Velanovich GERD-HRQL scores, PPI use, symptoms, satisfaction with the procedure, and wllingness to repeat the procedure again. Results: 11 of the 13 subjects could be reached by phone. GERD-HRQL scores were less than 9 or less in 10 subjects and 15 in one subject, The latter subject improved his score from 29 to 15, in all others score improved by more than 50%. All subjects would have agreed to do the procedure again. Mean satisfaction score was 7.7 (6-10) on a scale of 1-10. There was no dysphagia. Three subjects resumed PPI intake, (compared to 2 at the 2y follow up) 3 subjects require PPI at a reduced dose 1 subjects takes PPI only after a large meal and 4 subjects remained completely off PPI Conclusion: At 3 years, the procedure remained effective in improving the quality of life in moderate to severe GERD without causing dysphagia. PPI use was eliminated or reduced in 73% of subjects. All subjects remain satisfied with the procedure and would do it all over again. Further studies are necessary to validate these data and determine optimal staple placement.
Back to 2011 Program